Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease

BioMed Research International - United States
doi 10.1155/2019/8507583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”

Mediators of Inflammation
ImmunologyCell Biology
2018English

Response To: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”

Mediators of Inflammation
ImmunologyCell Biology
2018English

The Gut Microbiota of Nonalcoholic Fatty Liver Disease: Current Methods and Their Interpretation

Hepatology International
Hepatology
2015English

Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2013English

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases

Journal of Clinical Medicine
2019English

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Gut Microbiota and Non-Alcoholic Fatty Liver Disease: New Insights

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2013English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy